To provide further evidence, we isolated primary carcinoma cells from two human CRC specimens and found that TFF3 induced PTGS2 expression in a dose-dependent manner, which could be blocked by niclosamide (Supplementary Fig. 9k). The gene discussed is PTGS2; the disease is colorectal carcinoma.